388 related articles for article (PubMed ID: 19116975)
1. Time to treatment as an important factor for the response to methotrexate in juvenile idiopathic arthritis.
Albers HM; Wessels JA; van der Straaten RJ; Brinkman DM; Suijlekom-Smit LW; Kamphuis SS; Girschick HJ; Wouters C; Schilham MW; le Cessie S; Huizinga TW; Ten Cate R; Guchelaar HJ
Arthritis Rheum; 2009 Jan; 61(1):46-51. PubMed ID: 19116975
[TBL] [Abstract][Full Text] [Related]
2. Influence of methylenetetrahydrofolate reductase polymorphisms on efficacy and toxicity of methotrexate in patients with juvenile idiopathic arthritis.
Schmeling H; Biber D; Heins S; Horneff G
J Rheumatol; 2005 Sep; 32(9):1832-6. PubMed ID: 16142884
[TBL] [Abstract][Full Text] [Related]
3. Analysis of intracellular methotrexate polyglutamates in patients with juvenile idiopathic arthritis: effect of route of administration on variability in intracellular methotrexate polyglutamate concentrations.
Becker ML; van Haandel L; Gaedigk R; Lasky A; Hoeltzel M; Stobaugh J; Leeder JS
Arthritis Rheum; 2010 Jun; 62(6):1803-12. PubMed ID: 20191581
[TBL] [Abstract][Full Text] [Related]
4. The magnitude of early response to methotrexate therapy predicts long-term outcome of patients with juvenile idiopathic arthritis.
Bartoli M; Tarò M; Magni-Manzoni S; Pistorio A; Traverso F; Viola S; Magnani A; Gasparini C; Martini A; Ravelli A
Ann Rheum Dis; 2008 Mar; 67(3):370-4. PubMed ID: 17660217
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate improves the health-related quality of life of children with juvenile idiopathic arthritis.
Céspedes-Cruz A; Gutiérrez-Suárez R; Pistorio A; Ravelli A; Loy A; Murray KJ; Gerloni V; Wulffraat N; Oliveira S; Walsh J; Penades IC; Alpigiani MG; Lahdenne P; Saad-Magalhães C; Cortis E; Lepore L; Kimura Y; Wouters C; Martini A; Ruperto N;
Ann Rheum Dis; 2008 Mar; 67(3):309-14. PubMed ID: 17875547
[TBL] [Abstract][Full Text] [Related]
6. The role of subcutaneous administration of methotrexate in children with juvenile idiopathic arthritis who have failed oral methotrexate.
Alsufyani K; Ortiz-Alvarez O; Cabral DA; Tucker LB; Petty RE; Malleson PN
J Rheumatol; 2004 Jan; 31(1):179-82. PubMed ID: 14705239
[TBL] [Abstract][Full Text] [Related]
7. Serum osteopontin as a predictive marker of responsiveness to methotrexate in juvenile idiopathic arthritis.
Masi L; Ricci L; Zulian F; Del Monte F; Simonini G; Capannini S; De Martino M; Brandi ML; Falcini F
J Rheumatol; 2009 Oct; 36(10):2308-13. PubMed ID: 19684155
[TBL] [Abstract][Full Text] [Related]
8. A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate.
Ruperto N; Murray KJ; Gerloni V; Wulffraat N; de Oliveira SK; Falcini F; Dolezalova P; Alessio M; Burgos-Vargas R; Corona F; Vesely R; Foster H; Davidson J; Zulian F; Asplin L; Baildam E; Consuegra JG; Ozdogan H; Saurenmann R; Joos R; Pistorio A; Woo P; Martini A;
Arthritis Rheum; 2004 Jul; 50(7):2191-201. PubMed ID: 15248217
[TBL] [Abstract][Full Text] [Related]
9. Prediction of clinical non-response to methotrexate treatment in juvenile idiopathic arthritis.
Bulatovic M; Heijstek MW; Van Dijkhuizen EH; Wulffraat NM; Pluijm SM; de Jonge R
Ann Rheum Dis; 2012 Sep; 71(9):1484-9. PubMed ID: 22473625
[TBL] [Abstract][Full Text] [Related]
10. Randomized, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritis.
Woo P; Southwood TR; Prieur AM; Doré CJ; Grainger J; David J; Ryder C; Hasson N; Hall A; Lemelle I
Arthritis Rheum; 2000 Aug; 43(8):1849-57. PubMed ID: 10943876
[TBL] [Abstract][Full Text] [Related]
11. The effect of genotype on methotrexate polyglutamate variability in juvenile idiopathic arthritis and association with drug response.
Becker ML; Gaedigk R; van Haandel L; Thomas B; Lasky A; Hoeltzel M; Dai H; Stobaugh J; Leeder JS
Arthritis Rheum; 2011 Jan; 63(1):276-85. PubMed ID: 20954192
[TBL] [Abstract][Full Text] [Related]
12. Methotrexate is an effective treatment for chronic uveitis associated with juvenile idiopathic arthritis.
Foeldvari I; Wierk A
J Rheumatol; 2005 Feb; 32(2):362-5. PubMed ID: 15693100
[TBL] [Abstract][Full Text] [Related]
13. Adenosine and methotrexate polyglutamate concentrations in patients with juvenile arthritis.
Dolezalová P; Krijt J; Chládek J; Nemcová D; Hoza J
Rheumatology (Oxford); 2005 Jan; 44(1):74-9. PubMed ID: 15454631
[TBL] [Abstract][Full Text] [Related]
14. Time to methotrexate treatment in patients with rheumatoid arthritis referred to hospital.
de Thurah A; Nørgaard M; Johansen M; Stengaard-Pedersen K
Scand J Rheumatol; 2010; 39(1):19-25. PubMed ID: 20132066
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of measles, mumps and rubella revaccination in children with juvenile idiopathic arthritis treated with methotrexate and etanercept.
Borte S; Liebert UG; Borte M; Sack U
Rheumatology (Oxford); 2009 Feb; 48(2):144-8. PubMed ID: 19074187
[TBL] [Abstract][Full Text] [Related]
16. Guidelines for blood test monitoring of methotrexate toxicity in juvenile idiopathic arthritis.
Ortiz-Alvarez O; Morishita K; Avery G; Green J; Petty RE; Tucker LB; Malleson PN; Cabral DA
J Rheumatol; 2004 Dec; 31(12):2501-6. PubMed ID: 15570658
[TBL] [Abstract][Full Text] [Related]
17. [Methotrexate treatment in refractory juvenile rheumatoid arthritis].
Brik R
Harefuah; 1998 Dec; 135(11):509-11, 567. PubMed ID: 10911466
[TBL] [Abstract][Full Text] [Related]
18. Polyglutamation of methotrexate with common polymorphisms in reduced folate carrier, aminoimidazole carboxamide ribonucleotide transformylase, and thymidylate synthase are associated with methotrexate effects in rheumatoid arthritis.
Dervieux T; Furst D; Lein DO; Capps R; Smith K; Walsh M; Kremer J
Arthritis Rheum; 2004 Sep; 50(9):2766-74. PubMed ID: 15457444
[TBL] [Abstract][Full Text] [Related]
19. Functional and prognostic relevance of the -173 polymorphism of the macrophage migration inhibitory factor gene in systemic-onset juvenile idiopathic arthritis.
De Benedetti F; Meazza C; Vivarelli M; Rossi F; Pistorio A; Lamb R; Lunt M; Thomson W; Ravelli A; Donn R; Martini A;
Arthritis Rheum; 2003 May; 48(5):1398-407. PubMed ID: 12746913
[TBL] [Abstract][Full Text] [Related]
20. Predictors of poor response to methotrexate in polyarticular-course juvenile idiopathic arthritis: analysis of the PRINTO methotrexate trial.
Vilca I; Munitis PG; Pistorio A; Ravelli A; Buoncompagni A; Bica B; Campos L; Häfner R; Hofer M; Ozen S; Huemer C; Bae SC; Sztajnbok F; Arguedas O; Foeldvari I; Huppertz HI; Gamir ML; Magnusson B; Dressler F; Uziel Y; van Rossum MA; Hollingworth P; Cawkwell G; Martini A; Ruperto N;
Ann Rheum Dis; 2010 Aug; 69(8):1479-83. PubMed ID: 20525842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
